A detailed history of Prudential Financial Inc transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 50,370 shares of SAGE stock, worth $274,012. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,370
Previous 23,570 113.7%
Holding current value
$274,012
Previous $255,000 42.35%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$7.02 - $13.08 $188,136 - $350,544
26,800 Added 113.7%
50,370 $363,000
Q2 2024

Aug 13, 2024

BUY
$10.58 - $17.9 $79,297 - $134,160
7,495 Added 46.63%
23,570 $255,000
Q1 2024

May 14, 2024

BUY
$18.62 - $26.95 $299,316 - $433,221
16,075 New
16,075 $301,000
Q4 2022

Feb 14, 2023

SELL
$32.2 - $43.61 $9,660 - $13,083
-300 Reduced 1.0%
29,610 $0
Q3 2022

Nov 04, 2022

BUY
$32.28 - $43.27 $216,114 - $289,692
6,695 Added 28.84%
29,910 $1.17 Million
Q2 2022

Aug 15, 2022

SELL
$27.52 - $37.99 $1.36 Million - $1.88 Million
-49,520 Reduced 68.08%
23,215 $750,000
Q1 2022

May 13, 2022

SELL
$30.71 - $45.71 $1.91 Million - $2.85 Million
-62,300 Reduced 46.14%
72,735 $2.41 Million
Q4 2021

Feb 14, 2022

BUY
$37.06 - $47.11 $385,424 - $489,944
10,400 Added 8.34%
135,035 $5.74 Million
Q3 2021

Nov 15, 2021

SELL
$40.26 - $57.37 $1.22 Million - $1.73 Million
-30,200 Reduced 19.5%
124,635 $5.52 Million
Q2 2021

Aug 16, 2021

BUY
$54.88 - $79.29 $6.12 Million - $8.84 Million
111,545 Added 257.67%
154,835 $8.8 Million
Q1 2021

May 12, 2021

SELL
$70.65 - $96.76 $286,697 - $392,652
-4,058 Reduced 8.57%
43,290 $3.24 Million
Q4 2020

Feb 16, 2021

BUY
$58.41 - $89.06 $1.27 Million - $1.94 Million
21,758 Added 85.03%
47,348 $4.1 Million
Q3 2020

Nov 16, 2020

BUY
$41.13 - $62.45 $728,001 - $1.11 Million
17,700 Added 224.33%
25,590 $1.57 Million
Q2 2020

Aug 12, 2020

BUY
$25.95 - $43.15 $204,148 - $339,461
7,867 Added 34204.35%
7,890 $328,000
Q1 2020

Aug 05, 2021

SELL
$26.15 - $77.24 $626,318 - $1.85 Million
-23,951 Reduced 99.9%
23 $1,000
Q1 2020

May 12, 2020

BUY
$26.15 - $77.24 $624,801 - $1.85 Million
23,893 Added 29497.53%
23,974 $688,000
Q4 2019

Aug 05, 2021

SELL
$60.18 - $154.77 $2.08 Million - $5.35 Million
-34,592 Reduced 99.77%
81 $6,000
Q4 2019

Feb 11, 2020

BUY
$60.18 - $154.77 $2.08 Million - $5.35 Million
34,552 Added 28555.37%
34,673 $2.5 Million
Q3 2019

Aug 05, 2021

SELL
$140.29 - $189.96 $332,347 - $450,015
-2,369 Reduced 95.14%
121 $17,000
Q3 2019

Nov 13, 2019

BUY
$140.29 - $189.96 $331,224 - $448,495
2,361 Added 1830.23%
2,490 $349,000
Q2 2019

Aug 05, 2021

SELL
$157.85 - $183.09 $372,683 - $432,275
-2,361 Reduced 94.82%
129 $24,000
Q2 2019

Aug 08, 2019

BUY
$157.85 - $183.09 $379,471 - $440,148
2,404 Added 2795.35%
2,490 $0
Q1 2019

Aug 05, 2021

SELL
$89.33 - $163.65 $205,816 - $377,049
-2,304 Reduced 96.4%
86 $14,000
Q1 2019

May 15, 2019

BUY
$89.33 - $163.65 $209,121 - $383,104
2,341 Added 4777.55%
2,390 $0
Q4 2018

Aug 05, 2021

SELL
$81.94 - $139.71 $183,627 - $313,090
-2,241 Reduced 97.86%
49 $5,000
Q3 2018

Nov 07, 2018

BUY
$138.11 - $169.04 $13,811 - $16,904
100 Added 4.57%
2,290 $0
Q2 2018

Aug 13, 2018

SELL
$140.36 - $175.76 $284,930 - $356,792
-2,030 Reduced 48.1%
2,190 $0
Q1 2018

May 04, 2018

BUY
$152.15 - $192.33 $55,686 - $70,392
366 Added 9.5%
4,220 $0
Q4 2017

Feb 13, 2018

BUY
$60.72 - $167.34 $2,185 - $6,024
36 Added 0.94%
3,854 $635,000
Q3 2017

Nov 02, 2017

BUY
$61.4 - $88.52 $234,425 - $337,969
3,818
3,818 $238,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $323M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.